Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_391c83fca792eb7f88e731abaf38d305 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_789d4daaed8fd24cfffc812c07ede6f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e711d23be007c72d9a98b809a1db7fc0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23ec872637dd23aee3ea8f3de7258301 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5eb6c525e93546be6a42a6cee636cf84 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-42 |
filingDate |
2010-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47d31ed8d06c02e2651b4b8a27a1a11f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a487999f4106b9320a90ff4ea5ada977 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b673ed5da2bede587968ac8ddc26261 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5126b07fe2ed42047fef8c518252a8e |
publicationDate |
2011-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2011005388-A1 |
titleOfInvention |
Methods of treating hepatic encephalopathy |
abstract |
Treatment of hepatic encephalopathy using gastrointestinal specific antibiotics is disclosed. One example of a gastrointestinal specific antibiotic is rifaximin. The instant application also provides methods for determining if a subject has a neurological condition or hepatic encephalopathy by determining the critical flicker frequency and/or the venous ammonia level of the subject at two or more time points. The further provided are methods for treating these subjects. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633384-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2442803-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9629828-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10709694-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10335397-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10314828-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2607265-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2442803-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020276170-A1 |
priorityDate |
2009-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |